PANTHERx Rare Pharmacy
Edit

PANTHERx Rare Pharmacy

https://www.pantherxrare.com/
Last activity: 25.07.2024
Probably Closed
Categories: MedtechServiceSpecialty
PANTHERx Rare is a specialty pharmacy that provides personalized services to patients with rare diseases. They offer a multitude of services to ensure that patients are properly educated about their medication and have access to all available support services.
However, if you have any specific questions about their services or products, I’d be happy to help you find the answers!
Mentions
5
Location: United States, Pennsylvania, Pittsburgh

Investors 2

Mentions in press and media 5

DateTitleDescription
25.07.2024PANTHERx Rare Appoints Bansi Nagji as CEO; Rob Snyder appointed Executive ChairPITTSBURGH, July 25, 2024 /PRNewswire/ -- PANTHERx Rare, one of the nation's largest and fastest growing rare disease specialty pharmacies, today announced the appointment of Bansi Nagji as CEO effective August 1, 2024. In this role, Mr. Na...
06.05.2022VCs predict dark days ahead for the private marketsThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Kevin Baum, co-founder and CEO of farm management software startup Agriwebb, is trying to get ahe...
13.01.2022PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndromePITTSBURGH, Jan. 13, 2022 /PRNewswire/ -- PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distribution partner for...
30.12.2020Centene Adds Speciality Pharmacy To Health Plan PortfolioChairman and CEO of Centene, Michael F. Neidorff attends 2019 Forbes Healthcare Summit at the Jazz ... [+] at Lincoln Center on December 05, 2019 in New York City. (Photo by Steven Ferdman/Getty Images)Getty Images
03.12.2020PANTHERx Rare® Pharmacy Chosen as Partner by Alnylam Pharmaceuticals for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary Oxalate Levels

Reviews 0

Sign up to leave a review

Sign up Log In